Testing effectiveness (Phase 2)UnknownNCT05118256
What this trial is testing
Pirfenidone for the Reduction of Metabolic, Inflammatory and Fibrogenic Activity in Complicated Silicosis
Who this might be right for
SilicosisProgressive Massive FibrosisComplicated Silicosis
Instituto de investigación e innovación biomédica de Cádiz 18